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Percutaneous Osteoplasty for 
the Management of a Femoral Head
Metastasis: a Case Report
Percutaneous osteoplasty (POP) as a technical extension of percutaneous ver-
tebroplasty (PVP) has been used to treat malignant disease that affects the
skeletal system. POP has demonstrated good outcome for pain relief and func-
tional improvement. Few studies have reported on the efficiency of POP to treat
malignancies located in the femoral head. We designed a pilot study with the use
of POP to treat intractable pain caused by a femoral head metastatic tumor in a
43-year-old man. During the follow-up period, the patient experienced sustained
pain relief and improvement of quality of life that persisted for more than three
months.
ercutaneous vertebroplasty (PVP) is a safe and effective procedure for
the treatment of osteolytic vertebral metastases. In recent years, percuta-
neous osteoplasty (POP), as a technical extension of PVP, has been used
as a method for the treatment of osteolytic lesions due to a malignancy in the skeletal
system, including the acetabulum, sacrum, pubis, ischium, humerus and femur (1-8).
POP has been demonstrated to be highly efficient to provide pain relief and functional
improvement. Nevertheless, there are few reports on the use of POP for femoral head
osteolytic lesions. Furthermore, the effectiveness of POP for the treatment of these
lesions is not well known. In this report, we present a patient with osteolytic lesions of
the femoral head due to a lung cancer who experienced sustained pain relief and
improvement in quality of life following POP.
CASE REPORT
A 43-year-old man developed unremitting pain in the lower back and the right leg,
which especially increased while walking. Subsequently, the patient was admitted to
our hospital. The patient received bed rest for more than one month. Magnetic
resonance (MR) and emission computed tomography (ECT) images demonstrated the
presence of L3, S2 and S3 vertebral lesions that were metastatic tumors. Computed
tomography (CT) images demonstrated the presence of metastatic tumors that
involved the right acetabulum and the femoral head (Fig. 1) that were associated with
lung cancer (as determined by surgical pathology). Based on these clinical findings, the
patient was diagnosed with multiple metastatic bone tumors. The patient received
radiation therapy and experienced pain relief for one month. However, the patient
experienced recurrent pain and the pain had seriously affected sleep and the daily
activities of the patient. The pain was insensitive to drug administration. Furthermore,
side effects of opiate use such as effects on the gastrointestinal tract, had become
apparent. Due to the short life expectancy of the patient, a surgical procedure was not
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Pperformed. Consequently, a percutaneous procedure was
considered due to the potential ability to provide prompt
pain relief and functional improvement. The patient was
informed about the possible benefits and risks of the
treatment. Written informed consent was obtained from
the patient and his family.
Following detailed analyses of the lesions and adjacent
structures, we developed a modified procedure for the
treatment of the case. First, PVP was performed on the L3
lesion, and subsequently backache was alleviated. Second,
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Fig. 1. Procedure of percutaneous osteoplasty. 
A, B. Osteolytic lesion in right femoral head is depicted on coronal
and axial CT images.
C, D. Radiographs obtained during osteoplasty with patient in
prone position. Homogenous and sufficient distribution of bone
cement in lesion is shown. No evidence of polymethyl methacrylate
extravasation was observed.
E. Axial CT image was obtained at three-month follow-up examina-
tion. Homogenous distribution of bone cement can be observed.
No tumor regeneration is observed.nine days later, POP was performed on the right acetabu-
lum and femoral head. Prior to the performing the
procedure, it was essential to review the radiology films of
the patient to avoid causing injury to important vessels and
nerves. We administered local anesthesia to the patient
and placed the patient in the prone position on the
uniplane digital subtraction angiography (DSA, AXIOM
Artis dTA, Siemens, Erlangen, Germany) operating table.
A fluoroscope draped with a sterile sleeve was positioned
to allow an anteroposterior (AP) view. A small dermato-
tomy incision was made with a scalpel blade. Thereafter, a
bone puncture needle (13 G, Cook, Bloomington, IN) was
used; the needle penetrated the neck of the upper portion
of a femur lever attached to the femur flank along the
femur neck axis (Fig. 1C, D). We adjusted the cephalopod
and left-right angle according to positions depicted on
sagittal and axial images until the needle attained the
lesion, as seen for all fluoroscopy projections. After
removal of the needle, commercially available polymethyl
methacrylate (PMMA) (Simplex P, Stryker Howmedica
Osteonics, East Rutherford, NJ) was carefully injected into
the lesion under continuous fluoroscopic monitoring via
lateral and AP projections in order to ensure adequate
lesion filling and to avoid PMMA leakage. When bone
cement appeared at the neck of the femur cerebral cortex
edge, injection was ceased. A total of 5 ml PMMA was
injected into the right femur head. Post-procedural fluoro-
scopic observations showed optimal filling of the lesion
with no evidence of PMMA extravasation (Fig. 1C, D).
Subsequently, we used a bone puncture needle to
penetrate the right acetabulum. For successful penetration,
6 ml of PMMA was injected into the acetabulum.
Immediate post-procedural X-ray photographs
demonstrated good distribution of cement in the lesion and
there was no evidence of PMMA extravasation (Fig. 1C,
D). Blood pressure, an electrocardiogram and pulse
oximetry waveforms of the patient were monitored and
were observed to be steady during the procedure.
The patient experienced considerable pain relief and
functional enhancement, and the patient was able to walk
with the aid of crutches on the following day. The patient
was evaluated prior to and following the procedure for
reduction of pain intensity using a numerical rating scale
(NRS) with scores ranging from 0 (no pain) to 10 (worst
pain imaginable) (9). The NRS score decreased from 8 to 2
within 48 hours following POP. CT scans acquired three
months following the procedure revealed a stable femur
head with no further tumor growth and an unchanged
location of the instilled cement (Fig. 1E). The patient has
continued to be pain-free without medication and has
experienced no limitations in activity.
DISCUSSION
Metastatic cancer is the most common malignant disease
that affects the skeletal system. Many of the affected
patients endure severe pain and require a high dose of
opiates for pain relief. Femoral head osteolytic metastases
frequently cause severe pain on walking; minor movement
can induce a pathological fracture in patients diagnosed
with these types of metastases. Because of the disease,
most patients are restricted to bed rest throughout the day
that not only affects the quality of life but also increases
the chance of the development of bedsores and pneumonia
and significantly shortens survival time. The first goals of
treatment for a metastasis should be the alleviation of pain
and prevention of pathological fractures, which are
especially important in patients with femoral head metasta-
tic lesions, to avoid lower limb dysfunction. There are
several types of therapies available for the treatment of
these lesions. Many patients with metastases usually do not
have the opportunity to undergo surgery. Normally
administered treatments for this condition include
radiation therapy, chemotherapy and hormone therapy.
However, the results of these treatments are not satisfac-
tory; especially, none of these treatment options can
correct femoral head instability. POP is a minimally
invasive, low-cost treatment option for selected patients
with painful metastatic femoral head lesions. POP may
increase the intraosseous stability of the femoral head in
patients with osteolytic lesions and resistance to fracture.
During the follow-up period, the patient experienced
marked pain relief, improvement in walking and functional
recovery. We consider that POP is an effective, minimally
invasive local therapy that can be performed for the
treatment of femoral head metastatic lesions, and we
recommend that the procedure can be used as an alterna-
tive for the treatment of lesions resistant to medication or
radiotherapy. 
Moreover, the combination of POP with radiotherapy
and chemotherapy indicates a good prospect for the
treatment of metastases.
Currently, the mechanism by which pain relief is
achieved in patients with metastatic lesions treated with
bone cement injections is not sufficiently clear. The
injection of bone cement may aid in the stabilization of
microfractures, reduce thermal damage and may reduce
cytotoxicity in bones. Furthermore, the antineoplastic
effect of bone cement may play a significant role in
treating osteolysis (10, 11).
Based on the experience gained with this case, we were
able to discover the considerable potential value of POP
for the treatment of osteolytic metastases in the femoral
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procedure as an alternative treatment for lesions resistant
to medication or radiotherapy. This technique is similar to
PVP and consists of inserting a puncture needle to the
femoral head and the injection of PMMA into metastatic
lesions. However, based on a careful analysis of preopera-
tive imaging in patients to determine head cortical bone
integrity or for the destruction of a very small lesion, the
choice of the needle position should not be too high and
the needle should be preferably placed at the upper margin
of the femoral neck level to allow viscous bone cement to
be slowly injected under fluoroscopy. 
Although good results were obtained with this case, to
the best of our knowledge, this is the only report that has
described the application of POP for metastases treatment.
Therefore, further experience and studies in the future are
warranted to elucidate indications for surgery, surgical
puncture position, the amount of time required for
injection of bone cement and associated complications.
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